Abstract
Objective This study examines the serum nitric oxide (NO) as an indicator of poor outcome in neonatal sepsis. Study Design This prospective observational study was conducted in Dr. Hasan Sadikin General Hospital, Bandung, from September to November 2014. All subjects fulfilled inclusion criteria were tested serum NO metabolite at admission, then were followed up to determine the final outcome, grouped as Group I-good outcome, Group II-poor outcome. Logistic regression analysis was performed to determine independent variables associated with poor outcome, estimated as the odds ratio (OR) and the 95% confidence interval (95% CI). Results Fifty seven neonates were enrolled in this study. There was a good relation between NO level and poor outcome in neonatal sepsis (p<0.01). The level of NO metabolite was a significant independent factor of the poor outcome in neonatal sepsis in the multivariate regression logistic analysis (OR 25.975, p=0.000, 95% CI 4.354–154.952). It showed good discrimination with AUC 0.815 (95% CI 0.676 to 0.955), and good calibration (p=0.192). Conclusion A high serum NO level is independently associated with poor outcome in neonatal sepsis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: American Journal of Infectious Diseases and Microbiology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.